Obesity and smoking in patients with schizophrenia and normal controls: A case-control study

Fountoulakis, Konstantinos Ν.; Siamouli, Melina; Panagiotidis, Panagiotis; Magiria, Stamatia; Kantartzis, Sotiris; Papastergiou, Natalia; Shoretsanitis, George; Pantoula, Eleonora; Moutou, Katerina A.; Kouidi, Evangelia; Deres, Symeon

doi:10.1016/j.psychres.2008.11.018

Cited by 18 publications

(14 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fountoulakis et al . () reinforce the need for close physical health monitoring and the development of interventions to screen for and treat obesity in schizophrenia.…”

Section: Reoccurring Themesmentioning

confidence: 92%

“…Research investigating obesity and smoking in this target group found that the risk of obesity increases because of poor quality of life and antipsychotic treatment (Fountoulakis et al . ). The sample comprised of 105 individuals with schizophrenia and a control group including 156 individuals with no prior history of schizophrenia similar in age and sex to the schizophrenia group.…”

Section: Reoccurring Themesmentioning

confidence: 97%

See 1 more Smart Citation

Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses

McDaid

Smyth

2014

Psychiatric Ment Health Nurs

View full text Add to dashboard Cite

Metabolic abnormalities such as diabetes, obesity and dyslipidaemia are found in much higher rates in people with a diagnosis of schizophrenia when compared with the general population. This review discusses the most prevalent metabolic abnormalities associated with schizophrenia, their frequency and implications for mental health nurses (MHN). This review illuminates the need for MHN to acquire added awareness, knowledge and practical strategies in managing people at high risk of developing metabolic abnormalities associated with MetS. By doing this, it contributes to the literature by highlighting practical strategies for MHN in assessment and ongoing monitoring of metabolic abnormalities in clinical practice. This review highlights the need for MHN to be vigilant in monitoring a person's physical state on commencement and throughout treatment with antipsychotics. There is a need for an early detection monitoring system for people who are potentially at risk of developing metabolic abnormalities. The literature review aimed to investigate metabolic abnormalities associated with metabolic syndrome (MetS) in people diagnosed with schizophrenia; they are almost twice as likely to have metabolic risk factors and die approximately 20 years younger than the general population. MetS has become an issue of growing concern in mental health nursing. A comprehensive literature review was conducted utilizing various databases to address the reviews aim. Databases such as CINAHL Plus with full text (via EBSCO), MEDLINE(R) (OVID), PsycINFO and the COCHRANE library were accessed. The main metabolic abnormalities that emerged were: diabetes, obesity and dyslipidaemia. Antipsychotic medication also plays a vital role in a person's susceptibility to the development of MetS. It is critical that MHN has access to training and education in managing people at high risk of developing metabolic abnormalities associated with MetS. This review contributes to the literature by highlighting practical strategies for MHN in assessment and ongoing monitoring of metabolic abnormalities in clinical practice.

show abstract

“…Fountoulakis et al . () reinforce the need for close physical health monitoring and the development of interventions to screen for and treat obesity in schizophrenia.…”

Section: Reoccurring Themesmentioning

confidence: 92%

Section: Reoccurring Themesmentioning

confidence: 97%

Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses

McDaid

Smyth

2014

Psychiatric Ment Health Nurs

View full text Add to dashboard Cite

show abstract

“…High BMI in patients with schizophrenia is well-known (Fountoulakis et al, 2010;McEvoy et al, 2010), and is associated with reduced HRQoL (Renzaho et al, 2010). A study by Strassnig and colleagues (2003) showed reduced HRQoL in both patients with schizophrenia and in controls with high BMI (Strassnig et al, 2003).…”

Section: Comparisons With Other Studiesmentioning

confidence: 99%

Health-related quality of life and metabolic risk in patients with psychosis

Foldemo

Wärdig

Bachrach‐Lindström

et al. 2014

Schizophrenia Research

View full text Add to dashboard Cite

Health-related quality of life was assessed using the questionnaire EQ5D, both for patients and the population, and several other health status outcomes were used. Results: At 73%, schizophrenia and schizoaffective disorder were the most common diagnoses in the patient group. The results in patients (n=903) and population (n=7238) showed significant differences in lower EQ5D among patients. According to the definition by the International Diabetes Federation (IDF), elevated blood pressure was the only metabolic risk associated with lower HRQoL in patients. Raised LDL-cholesterol levels were also significantly related to lower HRQoL. Conclusion: patients suffering from psychosis had significantly lower HRQoL regarding all components in EQ5D, except for the pain/discomfort component.Almost half of the patient group met the criteria for metabolic syndrome. According to the IDF criteria, elevated blood pressure was the only metabolic risk factor that had an impact on HRQoL.

show abstract

“…People with schizophrenia have a high comorbidity for these diseases [1][2][3][4][5][6][7][8][9][10] as well as a higher prevalence of smoking compared with the general population [1][2][3][4][5][6][7][8]11,12] -between 54 and 70% [2,5,6,8,10,13], compared to 14% in the Swedish population [14]. Roick et al [15] showed that people with schizophrenia have a less healthy lifestyle when it comes to diet, exercise and smoking than the general population.…”

Section: Introductionmentioning

confidence: 99%

Health for smokers with schizophrenia – a struggle to maintain a dignified life

Sundgren

Hallqvist

Fredriksson

2015

Disability and Rehabilitation

View full text Add to dashboard Cite

Smokers with schizophrenia experience health as a struggle to maintain a dignified life and to maintain control over their psychotic symptoms. In smoking cessation programmes, health care providers must pay attention to the fear that people with schizophrenia have of losing control over their psychotic symptoms, if they stop smoking, and support them to find activities to replace smoking. This study suggests that to provide good support in health prevention for people with schizophrenia, it is vital for the health care provider to understand their unique personal experience of health and life style habits.

show abstract

Obesity and smoking in patients with schizophrenia and normal controls: A case-control study

Cited by 18 publications

References 18 publications

Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses

Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses

Health-related quality of life and metabolic risk in patients with psychosis

Health for smokers with schizophrenia – a struggle to maintain a dignified life

Contact Info

Product

Resources

About